Trial reportBMC musculoskeletal disorders2025
Application of saphenous nerve infrapatellar branch protection technique in total knee arthroplasty.
Trial report in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis randomized controlled trial conducted a comparative analysis of postoperative outcomes between a modified anteromedial incision with saphenous nerve protection and the traditional medial parapatellar approach in total knee arthroplasty (TKA). We aimed to test the hypothesis that the nerve-sparing modified technique would significantly reduce postoperative anterior knee numbness and pain while maintaining surgical feasibility.
methodsSixty-eight TKA candidates (January 2022-June 2023) were prospectively randomized into two groups: Modified (n = 34) and Traditional (n = 34) approaches. The modified technique featured an anteromedial incision with infrapatellar branch visualization and preservation, whereas the control group received the traditional medial parapatellar exposure. Primary outcomes included numbness area and the Visual Analog Scale score; secondary outcomes encompassed surgical parameters (duration, blood loss) and functional recovery (Hospital for Special Surgery Knee score).
resultsThirty one patients were randomized to the M group and 29 patients allocated to the T group. Compared to the T group, the M group demonstrated significantly lower VAS scores at 3 days, 7 days, and 2 weeks postoperatively, with statistical significance (P < 0.05). The M group showed a statistically significant reduction in the area of numbness compared to the T group at all postoperative follow-up intervals: 2 weeks, 1 month, 3 months, 6 months, and 1 year (P < 0.05 for all time points). However, postoperative HSS scores did not differ significantly between the M group and the T group at any follow-up interval (P > 0.05).
conclusionThe nerve-preserving modified approach achieved superior patient-reported outcomes (PROs) in reducing anterior knee numbness and early postoperative pain without compromising prosthesis implantation accuracy or functional recovery trajectories, suggesting its potential as a standardized refinement in TKA surgical protocols.
trial registrationChinese Clinical Trial Registry, ChiCTR2500107220, 6 August 2025, retrospectively registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.